Allergan Aesthetics
SKINVIVE
FDA-Approved Skin-Quality Injectable
- Duration
- 20-30 min
- Sessions
- 1 every 3-6 months
- Downtime
- Minimal (24-48 hr mild bumps)
SKINVIVE Treatment in Seoul
SKINVIVE by JUVÉDERM in Seoul — by Allergan Aesthetics (AbbVie). FDA-approved (May 2023) as the first HA microdroplet injectable indicated to improve cheek skin smoothness.
- Duration
- 20–30 min
- Sessions
- 1 every 3–6 months
- Downtime
- Minimal (24–48 hr mild bumps)
- Peak Result
- 1 month
Results Over Time
SKINVIVE by JUVÉDERM is an HA microdroplet skin-quality injectable that improves cheek smoothness and hydration from within.
01Immediately post
Small injection papules and mild redness; typically resolve within 24–48 hours.
02Days 1–2
Faint bumps and mild tenderness may persist; most patients cover with makeup from Day 2.
03Week 1
Injection marks fully settle; early smoothness and hydration benefits become apparent.
041 month
Peak measured improvement in cheek smoothness per the FDA pivotal trial (P220046).
053–6 months
Skin-quality benefits sustained through 6 months in trial; gradual return to baseline thereafter.
Images are AI-generated for illustrative purposes only.
SKINVIVE by JUVÉDERM
Allergan Aesthetics' SKINVIVE is FDA-approved (PMA P220046, May 2023) — the first and only HA microdroplet injectable approved to improve cheek skin smoothness.
HA Microdroplet Technology
A modified HA formulation delivered as micro-droplets into the skin for smoothness and deep hydration — not volumizing.
Single Treatment
A single session with results building over 2–4 weeks and sustained through ~6 months in clinical trial.
FDA-Approved & Safe
The first HA microdroplet injectable FDA-approved to improve cheek skin smoothness.
Treatment Process
01Skin Assessment
The dermatologist evaluates skin quality and hydration needs.
02Precise Injection
SKINVIVE micro-droplets are injected into the cheeks using a fine needle.
03Quick Treatment
Treatment covers both cheeks in approximately 15–20 minutes.
04Visible Results
Results are immediate, with continued improvement over 2–4 weeks.
Recovery & Care
First 24 hours
Avoid vigorous exercise, alcohol, and heat (saunas, hot showers) to minimize bruising and swelling.
Days 2–3
Makeup may be applied once injection marks settle; use gentle cleansers. Avoid massaging the treated area.
Week 1
Continue daily broad-spectrum SPF 30+. Resume normal skincare and exercise.
6-month maintenance
Effects sustained through ~6 months per trial; schedule maintenance at 4–6 months for continuous benefit.
Frequently Asked Questions
Q.Is SkinVive the same as Juvéderm filler?
No. SkinVive is a different product formulated specifically for skin quality improvement, not volumizing. It uses a modified HA formulation designed for micro-droplet injection into the skin.
Q.How long does SkinVive last?
Clinical studies show results lasting up to 6 months from a single treatment. Most patients report noticeable improvement for 3-6 months.
References1
The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]SKINVIVE by JUVÉDERM Premarket Approval (P220046). U.S. Food & Drug Administration (PMA P220046) (2023).
Notice
- Active skin infections or open wounds in the target area
- History of severe or multiple allergies / anaphylaxis
- Known hypersensitivity to hyaluronic acid or gram-positive bacterial proteins
- Bleeding disorders or use of anticoagulants without physician clearance
- Pregnancy or breastfeeding (not studied — avoid as precaution)
Session summary & comparison
| Item | Details |
|---|---|
| Treatment time | About 15-20 minutes (both cheeks) |
| Sessions | Single session; results last 3-6 months |
| Pain & comfort | Fine-needle intradermal micro-droplets across the cheeks |
| Downtime | Minimal — mild redness and small bumps settle within 24-48 hours; avoid heavy exercise and alcohol for 24 hours |
| Onset of results | Immediate, with continued improvement over 2-4 weeks |
| Regulatory status | FDA-approved (May 2023) — the first HA microdroplet injectable cleared to improve skin smoothness of the cheeks |
Related procedures
Evidence & comparison guides
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step